GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kairos Pharma Ltd (AMEX:KAPA) » Definitions » FCF Yield %

KAPA (Kairos Pharma) FCF Yield % : -9.78 (As of Dec. 11, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Kairos Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Kairos Pharma's Trailing 12-Month Free Cash Flow is $-2.09 Mil, and Market Cap is $21.33 Mil. Therefore, Kairos Pharma's FCF Yield % for today is -9.78%.

The historical rank and industry rank for Kairos Pharma's FCF Yield % or its related term are showing as below:

KAPA' s FCF Yield % Range Over the Past 10 Years
Min: -12.03   Med: 0   Max: 0.46
Current: -9.78

During the past 4 years, the highest FCF Yield % of Kairos Pharma was 0.46%. The lowest was -12.03%. And the median was 0.00%.

KAPA's FCF Yield % is ranked better than
51.69% of 1507 companies
in the Biotechnology industry
Industry Median: -12.58 vs KAPA: -9.78

Kairos Pharma's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

Kairos Pharma FCF Yield % Historical Data

The historical data trend for Kairos Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kairos Pharma FCF Yield % Chart

Kairos Pharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23
FCF Yield %
- - - -

Kairos Pharma Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -40.06

Competitive Comparison of Kairos Pharma's FCF Yield %

For the Biotechnology subindustry, Kairos Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kairos Pharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kairos Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Kairos Pharma's FCF Yield % falls into.


Kairos Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Kairos Pharma's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=0.081 / 0
=N/A%

Kairos Pharma's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-2.02 * 4 / 20.169476
=-40.06%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kairos Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Kairos Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Kairos Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kairos Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kairos Pharma Ltd (AMEX:KAPA) » Definitions » FCF Yield %
Comparable Companies
Traded in Other Exchanges
N/A
Address
2355 Westwood Boulevard, 139, Los Angeles, CA, USA, 90064
Website
https://kairospharma.com
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.